Patent classifications
C07D223/12
HISTONE DEACETYLASE INHIBITORS
Provided herein are compounds and methods for inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
HISTONE DEACETYLASE INHIBITORS
Provided herein are compounds and methods for inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
Histone deacetylase inhibitors
Provided herein are compounds and methods for inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
Histone deacetylase inhibitors
Provided herein are compounds and methods for inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
Phenyl amino piperidine mTORC inhibitors and uses thereof
The present invention provides compounds, compositions thereof, and methods of using the same.
Phenyl amino piperidine mTORC inhibitors and uses thereof
The present invention provides compounds, compositions thereof, and methods of using the same.
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.
HISTONE DEACETYLASE INHIBITORS
Provided herein are compounds and methods for inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
HISTONE DEACETYLASE INHIBITORS
Provided herein are compounds and methods for inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).